BEAM
Price
$17.64
Change
-$0.21 (-1.18%)
Updated
Aug 8, 01:52 PM (EDT)
Capitalization
1.81B
94 days until earnings call
PRME
Price
$3.56
Change
-$0.12 (-3.26%)
Updated
Aug 8, 10:51 AM (EDT)
Capitalization
655.76M
84 days until earnings call
Interact to see
Advertisement

BEAM vs PRME

Header iconBEAM vs PRME Comparison
Open Charts BEAM vs PRMEBanner chart's image
Beam Therapeutics
Price$17.64
Change-$0.21 (-1.18%)
Volume$877
Capitalization1.81B
Prime Medicine
Price$3.56
Change-$0.12 (-3.26%)
Volume$10.79K
Capitalization655.76M
BEAM vs PRME Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PRME commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BEAM: $17.86 vs. PRME: $3.68)
Brand notoriety: BEAM and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. PRME: 148%
Market capitalization -- BEAM: $1.81B vs. PRME: $655.76M
BEAM [@Biotechnology] is valued at $1.81B. PRME’s [@Biotechnology] market capitalization is $655.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and PRME are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • PRME’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BEAM and PRME are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -9.39% price change this week, while PRME (@Biotechnology) price change was -1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.22%. For the same industry, the average monthly price growth was +6.60%, and the average quarterly price growth was +12.79%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

PRME is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Biotechnology (+0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.81B) has a higher market cap than PRME($656M). PRME YTD gains are higher at: 26.027 vs. BEAM (-27.984). PRME has higher annual earnings (EBITDA): -200M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. PRME (144M). PRME has less debt than BEAM: PRME (121M) vs BEAM (158M). BEAM has higher revenues than PRME: BEAM (63.6M) vs PRME (3.85M).
BEAMPRMEBEAM / PRME
Capitalization1.81B656M275%
EBITDA-399.03M-200M200%
Gain YTD-27.98426.027-108%
P/E RatioN/AN/A-
Revenue63.6M3.85M1,654%
Total Cash1.22B144M847%
Total Debt158M121M131%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPRME
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDIX35.330.20
+0.57%
Artisan International Advisor
REQSX22.850.02
+0.09%
Russell Inv Equity Income C
GLDCX30.04N/A
N/A
Gabelli Gold C
VRKSX11.15N/A
N/A
Virtus KAR Small-Mid Cap Growth R6
GIIZX13.86N/A
N/A
GuideStone Funds Intl Eq Idx Investor

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-9.58%
CRSP - PRME
59%
Loosely correlated
-0.67%
RXRX - PRME
56%
Loosely correlated
-1.28%
BEAM - PRME
55%
Loosely correlated
-2.40%
CRBU - PRME
49%
Loosely correlated
-3.72%
CCCC - PRME
48%
Loosely correlated
+31.63%
More